Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders
出版年份 2023 全文链接
标题
Immune Checkpoint Inhibitors in Patients with Pre-existing Neurologic Autoimmune Disorders
作者
关键词
-
出版物
Current Neurology and Neuroscience Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-23
DOI
10.1007/s11910-023-01306-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
- (2023) John R Corboy et al. LANCET NEUROLOGY
- Outcome of patient with myasthenia gravis with the use of immunotherapy in metastatic Merkel cell carcinoma
- (2022) Sarah Williams et al. Oxford Medical Case Reports
- Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge
- (2022) Raju Vaddepally et al. Biomedicines
- Immune checkpoint inhibition in patients with inactive pre-existing neuromuscular autoimmune diseases
- (2022) Andrew Snavely et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors
- (2022) Sarah E Conway et al. Multiple Sclerosis Journal
- Management of Adverse Radiation Effect Associated with Stereotactic Radiosurgery of Brain Metastasis in Multiple Sclerosis
- (2022) Elisa K. Liu et al. Advances in Radiation Oncology
- Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
- (2021) Julianne D. Twomey et al. AAPS Journal
- Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data
- (2021) Virginia Calvo et al. Lung Cancer Management
- CNS and PNS manifestation in immune checkpoint inhibitors: A systematic review
- (2021) Erum Khan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Complete Pathologic Response to Pembrolizumab and Axitinib in a Patient With Sarcomatoid RCC and Ocrelizumab-Treated Multiple Sclerosis
- (2021) Kevin Neuzil et al. UROLOGY
- How we identify and treat neuromuscular toxicity induced by immune checkpoint inhibitors
- (2021) B. Jordan et al. ESMO Open
- Neurologic complications of immune checkpoint inhibitors
- (2020) Alexandra M Haugh et al. Expert Opinion On Drug Safety
- Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature
- (2020) Pooja Raibagkar et al. JOURNAL OF NEUROIMMUNOLOGY
- Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes
- (2020) Elia Sechi et al. NEUROLOGY
- Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
- (2020) Omar Hasan Ali et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Central Nervous System Demyelination Associated With Immune Checkpoint Inhibitors: Review of the Literature
- (2020) Marcos C. B. Oliveira et al. Frontiers in Neurology
- Multiple sclerosis outcomes after cancer immunotherapy
- (2019) Catherine R. Garcia et al. Clinical & Translational Oncology
- Metastatic Merkel cell carcinoma and myasthenia gravis: contraindication for therapy with immune checkpoint inhibitors?
- (2019) Anne Zaremba et al. Journal for ImmunoTherapy of Cancer
- A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes
- (2019) AlexanderJ. Gill et al. JOURNAL OF NEUROIMMUNOLOGY
- Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer
- (2019) Marzia Anita Lucia Romeo et al. JOURNAL OF NEUROLOGY
- Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
- (2019) Houssein Safa et al. Journal for ImmunoTherapy of Cancer
- Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
- (2019) Guillaume Manson et al. Journal for ImmunoTherapy of Cancer
- Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease
- (2018) Noha Abdel-Wahab et al. ANNALS OF INTERNAL MEDICINE
- Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
- (2018) Katharina C. Kähler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Nivolumab-induced Limbic Encephalitis with Anti-Hu Antibody in a Patient With Advanced Pleomorphic Carcinoma of the Lung
- (2018) Hiroki Matsuoka et al. Clinical Lung Cancer
- Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease
- (2018) François-Xavier Danlos et al. EUROPEAN JOURNAL OF CANCER
- Relapsed Myasthenia Gravis after Nivolumab Treatment
- (2018) Ayumi Mitsune et al. INTERNAL MEDICINE
- Clinical spectrum of neuromuscular complications after immune checkpoint inhibition
- (2018) Araya Puwanant et al. NEUROMUSCULAR DISORDERS
- Refractory myasthenia gravis exacerbation triggered By pembrolizumab
- (2017) Damien E. Earl et al. MUSCLE & NERVE
- Inflammatory CNS disease caused by immune checkpoint inhibitors: status and perspectives
- (2017) Lidia M. Yshii et al. Nature Reviews Neurology
- Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma
- (2017) Kyriakos P. Papadopoulos et al. ONCOLOGIST
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
- (2016) Lisa Ann Gerdes et al. ANNALS OF NEUROLOGY
- Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
- (2016) A. M. Menzies et al. ANNALS OF ONCOLOGY
- Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab
- (2016) K. H. Vincent Lau et al. MUSCLE & NERVE
- Myasthenia gravis exacerbation associated with pembrolizumab
- (2016) Julia Zhu et al. MUSCLE & NERVE
- P04.07 Relapse in a paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab
- (2016) L. Gómez Vicente et al. NEURO-ONCOLOGY
- CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment
- (2016) Yonghao Cao et al. NEUROLOGY
- Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
- (2016) Stacy Ellen Hatcher et al. JAMA Neurology
- Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- (2016) Douglas B. Johnson et al. JAMA Oncology
- Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma
- (2014) Edward J Gettings et al. Multiple Sclerosis Journal
- Ipilimumab in patients with melanoma and autoimmune disease
- (2014) Chrisann Kyi et al. Journal for ImmunoTherapy of Cancer
- Does change in acetylcholine receptor antibody level correlate with clinical change in myasthenia gravis?
- (2013) Donald B. Sanders et al. MUSCLE & NERVE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started